All Stories

  1. Perceived levels of social stigma following HIV notification: Insights from Brazilian blood centers
  2. Oligosymptomatic infection by SARS-Cov-2 in catastrophic antiphospholipid syndrome, a singular coincidence: a case report in an Ecuadorian hospital
  3. Prevalence and clinical consequences of Hepatitis C virus infection in patients undergoing hematopoietic stem cell transplantation
  4. Detection of unreported usage of the antiretroviral drug lamivudine in two blood donors
  5. Survival analysis over a 20-year period of a Brazilian cohort of blood donors coinfected HIV-HCV
  6. Factors Associated with Leg Ulcers in Adults with Sickle Cell Disease in Brazil
  7. Economic evaluation of plerixafor addition in the mobilization and leukapheresis of hematopoietic stem cells for autologous transplantation: a systematic review
  8. Improved detection of hepatitis C virus‐positive blood donors and determination of infection status
  9. Predicting SARS-CoV-2 Variant Spread in a Completely Seropositive Population Using Semi-Quantitative Antibody Measurements in Blood Donors
  10. Survival among children and adults treated with granulocyte transfusions: Twenty years’ experience at a Brazilian blood center
  11. Prevalence and Risk Factors for Human T-Cell Lymphotropic Virus (HTLV) in Blood Donors in Brazil—A 10-Year Study (2007–2016)
  12. The impact of immediate adverse donation reactions on the return of volunteers undergoing platelet apheresis
  13. Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial
  14. Knowledge of Hepatitis C virus vertical transmission and subsequent pregnancy outcome in virus-positive female blood donors
  15. Influence of unreported HIV prophylaxis on the kinetics of post‐blood donation HIV seroconversion
  16. Higher risk of death from COVID-19 in low-income and non-White populations of São Paulo, Brazil
  17. Occult and active hepatitis B virus detection in donated blood in São Paulo, Brazil
  18. HIV primary drug resistance and associated HIV risk factors among HIV positive blood donors in Brazil from 2007 to 2017
  19. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing
  20. Detection and analysis of blood donors seropositive for syphilis
  21. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
  22. Declining antibody levels to Trypanosoma cruzi correlate with polymerase chain reaction positivity and electrocardiographic changes in a retrospective cohort of untreated Brazilian blood donors
  23. Characterization of HIV risks in a Brazilian sickle cell disease population
  24. 10‐year analysis of human immunodeficiency virus incidence in first‐time and repeat donors in Brazil
  25. Association of HIV infection with clinical and laboratory characteristics of sickle cell disease
  26. Obesity and ABO blood group: Is there an association?
  27. Are different motivations and social capital score associated with return behaviour among Brazilian voluntary non‐remunerated blood donors?
  28. Validation of a formula predictive of peripheral blood stem cell yield and successful collection in healthy allogeneic donors
  29. Prevalence of serologic markers of transfusion and sexually transmitted infections and their correlation with clinical features in a large cohort of Brazilian patients with sickle cell disease
  30. Quality of life in pre-adolescent children with sickle cell disease in Brazil
  31. Test seeking: are healthcare professionals referring people to blood centers for infections marker testing?
  32. Social and behavioral characteristics of male blood donors and their sexual partners: an analysis to define risk subsets
  33. Does deferral for high‐risk behaviors improve the safety of the blood supply?
  34. Molecular characterization of viruses associated with encephalitis in São Paulo, Brazil
  35. Cytomegalovirus causes pulmonary embolism and can be treated with rivaroxaban
  36. Cascade of care and predictors of loss to follow-up among patients with hepatitis C.
  37. Text message, letter, or telephone call reminders to improve return of blood donors for counseling.
  38. Duration of Dengue Viremia in Blood Donors and Relationships Between Donor Viremia, Infection Incidence and Clinical Case Reports During a Large Epidemic
  39. Quality of life among blood donors with hepatitis B and hepatitis C
  40. Evolution of hepatitis C sutypes in São Paulo, Brazil
  41. Risk factors for anemia and iron deficiency among blood donation candidates
  42. Thrombosis and hereditary hemochromatosis mutations
  43. Risk factors among blood donors with positive syphilis markers
  44. Tools to improve hemovigilance
  45. Contribution of REDS to blood safety in Brazil
  46. Quality of live in chronic hepatitis C and B
  47. HCV genotypes, drug-resistence and risk factors for infection
  48. HIV knowledge and attitutes
  49. Prevalence of T. pallidum DNA among blood donors with positive tests for syphilis
  50. Response to: Chagas cardiomyopathy incidence
  51. Undisclosed HIV risk factors among blood donors
  52. HIV risk factors among blood donors in Brazil
  53. Chagas cardiomyopathy incidence
  54. Policies to mitigate TRALI in Brazil
  55. Temporal distribution of Brazilian blood donors
  56. Donors motivation and social capital
  57. Social capital and test seeking
  58. HBV and HCV markers among blood donors in Brazil
  59. Patterns of return among blood donors in Brazil
  60. Number of sexual partners and serologic markers among Brazilian blood donors
  61. Retention of blood donors
  62. CUE policies in Brazil
  63. Performance of dual immunoassay (IAs) screening in Brazil
  64. Impact of donors education on behavioral deferral
  65. 2-Red Blood Cell (2-RBC) and iron stores
  66. Comparison of two different methods of anemia screening in women
  67. Efficacy of donor arm disinfection
  68. Blood donors with syphilis in Sao Paulo, Brazil.
  69. Succesful outcome in poor-prognostic trombocitopenic trombotic purpura (TTP)
  70. HIV infection risk in Sao Paulo donors
  71. Deferral criteria on prevention of Creutzfeldt Jakob Disease and its variants
  72. Elevated ALT in blood donors
  73. Response to: anti-HBc isolated in blood donors
  74. p24 donor screening in Brazil
  75. Isolated anti-HBc in blood donors
  76. Serologic diagnosis of Chagas´Disease